SandboxAQ AI Drug Discovery Platform
Vertical application
Overview
SandboxAQ's AI drug discovery platform uses machine learning and physics-based simulation to predict how molecules will bind, behave, and perform as drugs before lab testing. It helps teams screen millions of compounds computationally, prioritize the most promising candidates, and de-risk hard-to-drug targets faster than traditional wet-lab-first pipelines. The platform offers enterprise licensing with full model and data ownership.
- Pricing model
- Enterprise / custom quote
- Deployment
- SaaS (vendor-hosted), On-device / edge, API / SDK
- Regions served
- United States, Global
- Categories
- Language (LLM / NLP), Process automation, Vertical application, Biotechnology, API / SDK, Predictive / classical ML, Business intelligence, SaaS (vendor-hosted), On-device / edge, Enterprise / custom quote
- Last updated
- 4 October 2026
- Published
- 4 October 2026
Use cases
Deployment options
Data sources & provenance
Where this information came from, how it was checked and when it was last looked at. “Last updated” records a change to the record — it does not mean the record was verified.
- Data quality
- Data quality: Editorially Reviewed
- Primary source
- sandboxaq.com
- Sources cited
- 1
- Last reviewed
- 28 September 2026
- Last updated
- 4 October 2026
Spotted something out of date?
Anyone can suggest a correction — you don't need an account. An editor checks every suggestion against the sources before the record changes.